Calcium and vitamin D improve bone density in patients taking antiepileptic drugs

diet, home health

A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin Dsupplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs). The results published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggest that risedronate, a bisphosphonate, may help to prevent new vertebral fractures when taken with calcium andvitamin D supplementation.vitamin D

Many patients with epilepsy are required to take chronically an AED such as phenytoin, phenobarbital, carbamazepine, primidone, and valproate alone or in combination to control seizures. There is much medical evidence reporting that these AEDs may accelerate bone loss, increasing the risk of osteoporotic fractures. In fact, previous studies found that more than 50% of adults with epilepsy who use AEDs showed decreased bone mass in their hips or spine and the overall fracture risk of patients with epilepsy is considered to be larger than the normal population.

“Long-term use of AEDs is associated with loss of bone mass and increased risk of osteoporosis,” explains Dr. Antonio Lazzari with the VA Boston Healthcare System in Massachusetts and lead author of the present study. “Our study is the first longitudinal trial of a bisphosphonate (risedronate), along with calcium and vitamin D supplementation, in preventing and treating bone loss in male veterans with epilepsy receiving AED therapy.”

The antiepileptic drug and osteoporosis prevention trial (ADOPT) was a prospective two-year randomized, double-blind, placebo-controlled phase IV clinical trial of 80 male veterans with epilepsy who were treated with an AED for a minimum of two years. All participants received calcium and vitamin D supplements, and were randomized to risedronate or placebo. Subjects received total body, hip, and spine bone density assessments at baseline, one year and two years following their study enrollment.

Baseline characteristics of subjects were similar and 53 patients completed the two-year study. Significant improvement in bone density compared to baseline was observed in 69% and 70% of patients in the placebo and active drug groups, respectively. Patients taking risedronate displayed a significant increase in bone density at the lumbar spine, compared to subjects in the placebo group.

Dr. Lazzari concludes, “Our findings suggest calcium and vitamin D with or without risedronate improves bone density in epilepsy patients taking AEDs. However five new vertebral fractures were observed in the placebo group and none in the active medication group. Adding risedronate to the supplements appears to prevent new fractures in this group of veterans.”

The authors caution that therapy with antiresorptive agents should be limited to five years to reduce side effects associated with long-term use of this group of drugs including osteonecrosis of the jaw and atypical femoral fractures. Researchers recommend future studies of efficacy and safety with the long-term use of bisphosphonates in patients with epilepsy.

McKinney
  • 1515 Heritage Dr., Ste. 214
    McKinney, TX 75069
  • 214-491-1626
  • Fax: 214-491-1627
  • Toll Free: 877-558-9920
Athens
  • 311 South Palestine
    Athens, TX 75751
  • 903-677-8301
  • Fax: 903-677-8310
  • Toll Free: 877-390-7827
Huntsville
  • 116-D Medical Park Lane
    Huntsville, TX 77340
  • 936-291-7284
  • Fax: 936-436-9308
  • Toll Free: 855-294-7284
The Woodlands
  • 24800 Pitkin Rd., Ste. B
    Spring, TX 77386
  • 281-364-9161
  • Fax: 281-298-1458
  • Toll Free: 800-955-9161
Beaumont
  • 5550 Eastex Freeway, Suite EE
    Beaumont, TX 77708
  • 409-924-9906
  • Fax: 409-924-7338
  • Toll Free: 877-924-9906
Katy
  • 1260 Pin Oak Road,
    Suite 111
    Katy, TX 77494
  • 281-574-3701
  • Fax: 281-574-3710
  • Toll Free: 866-315-2824
Corpus Christi
  • 3765 South Alameda Street, Suite 251
    Corpus Christi, TX 78411
  • 361-884-4299
  • Fax: 361-888-8914
  • Toll Free: 800-456-9050
© 2013 Pathfinder Home Health | Design by Newton Design and MarketingNewton